Human Genome Project

• Nucleus further personalizes these risk assessments by integrating personal and lifestyle factors into their analysis — such as age, cholesterol levels, blood pressure, and BMI.
• Nucleus will also offer pre-orders for its premium clinical-grade whole-genome sequencing (WGS) service, in which a customer's entire set of DNA will be read and analyzed.
• Nucleus is proud to sequence all customer samples in the U.S. on Illumina's NovaSeq X Plus, the sequencing company's newest and most innovative high-throughput sequencing instrument.
• Working with Illumina, Nucleus is leveraging this latest sequencing technology to make WGS broadly accessible to power personalized healthcare.

• NORTHFIELD, N.H., Dec. 19, 2023 /PRNewswire-PRWeb/ -- Spaulding Academy & Family Services recently announced the hiring of Bethany Earls, SHRM-SCP into the role of Vice President of Human Resources.
• "Bethany's exceptionally strong HR background coupled with her experience in human services is exactly what Spaulding Academy & Family Services needs to foster a culture that fully supports staff, children, and families," said Todd Emmons, CEO & President, Spaulding Academy & Family Services.
• In her role as VP of Human Resources, Earls oversees the human resources department and is responsible for ensuring Spaulding Academy & Family Services utilizes a strategic approach to human resources and fosters a supportive, creative, and positive work culture for employees.
• "Bethany's exceptionally strong HR background coupled with her experience in human services is exactly what Spaulding Academy & Family Services needs to foster a culture that fully supports staff, children, and families," said Todd Emmons, CEO & President, Spaulding Academy & Family Services.

• The specific details of these technologies are, of course, a world apart.
• As scholars of the future of innovation, we explore these parallels in a new commentary in the journal Nature Nanotechnology.

Nanotech excitement and fear

• In the late 1990s and early 2000s, nanotechnology transitioned from a radical and somewhat fringe idea to mainstream acceptance.
• The era saw public protests against nanotechnology and – disturbingly – even a bombing campaign by environmental extremists that targeted nanotechnology researchers.
• These included potential health and environmental impacts, social and ethical issues, regulation and governance, and a growing need for public and stakeholder collaboration.
• The result was a profoundly complex landscape around nanotechnology development that promised incredible advances yet was rife with uncertainty and the risk of losing public trust if things went wrong.

How nanotech got it right

• At the time, working on responsible nanotechnology development felt like playing whack-a-mole with the health, environment, social and governance challenges presented by the technology.
• This included multistakeholder partnerships, consensus standards, and initiatives spearheaded by global bodies such as the Organization for Economic Cooperation and Development.
• As a result, many of the technologies people rely on today are underpinned by advances in nanoscale science and engineering.
• In the early 2000s, the initiative brought together representatives from across the government to better understand the risks and benefits of nanotechnology.

Experts only at the table

• Yet despite similar aspirations around AI, these same levels of diversity and engagement are missing.
• The White House has prioritized consultations with AI company CEOs, and Senate hearings have drawn preferentially on technical experts.
• More importantly, they bring a diversity of expertise and perspectives to the table that is essential for the successful development of an advanced technology like AI.

The clock is ticking

• But this will happen only if society applies the lessons from past advanced technology transitions like the one driven by nanotechnology.
• The early days of an advanced technology transition set the trajectory for how it plays out over the coming decades.
• He was previously the co-chair of the Nanotechnology Environmental and Health Implications Working Group, and was Chief Science Advisor to the Project on Emerging Nanotechnologies.

• He was a leader in the Human Genome Project and a key contributor to the technology that enabled one of the earliest rapid tests for COVID-19.
• Galas and his team focused on developing and applying innovative mathematical methods, providing new computational tools to seek out and validate genetic interactions significant to this research.
• Brooks Simpson, WRF's board chair, said, "David was an incredible board member and mentor to all of us.
• That will always remain a hallmark of our contributions to the research engines in the region."